Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells

BACKGROUND: Triple negative breast cancer is more aggressive than other breast cancer subtypes and constitutes a public health problem worldwide since it has high morbidity and mortality due to the lack of defined therapeutic targets. Resistance to chemotherapy complicates the course of patients’ tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Español, Alejandro, Sanchez, Yamila, Salem, Agustina, Obregon, Jaqueline, Sales, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244968/
https://www.ncbi.nlm.nih.gov/pubmed/35949430
http://dx.doi.org/10.5306/wjco.v13.i6.505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244968/
https://www.ncbi.nlm.nih.gov/pubmed/35949430
http://dx.doi.org/10.5306/wjco.v13.i6.505

Ejemplares similares